Natera, Inc.
NTRA- 交易所
- Nasdaq
- 產業
- Services-Medical Laboratories
- SEC CIK
- 0001604821
內部人交易
每一列是一份 Form 4 申報裡同一種交易的合計。預設只顯示公開市場買進(P)與賣出(S);要看公司授予、行使選擇權等其他代碼,請調整篩選條件。
| 申報時間(美東) | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/9/2521:35 ET | 2026/9/23 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −1.81 萬 | $388.0078 | −$700.9 萬 | 9,000 | −66.7% | SEC10b5-1 |
| 2026/9/1721:35 ET | 2026/9/15–9/16 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −9,150 | $351.4912 | −$321.61 萬 | 22.13 萬 | −4.0% | SEC10b5-1 |
| 2026/9/1621:35 ET | 2026/9/14–9/15 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −10 萬 | $340.9726 | −$3,409.73 萬 | 212.54 萬 | −4.5% | SEC10b5-1 |
| 2026/9/1621:35 ET | 2026/9/15 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −2,000 | $350.0072 | −$70 萬 | 0 | −100.0% | SEC10b5-1 |
| 2026/9/1121:35 ET | 2026/9/11 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −5 萬 | $327.9653 | −$1,639.83 萬 | 222.54 萬 | −2.2% | SEC10b5-1 |
| 2026/9/321:35 ET | 2026/9/1–9/2 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | S賣出Common Stock | −1.82 萬 | $325.8759 | −$591.79 萬 | 11.09 萬 | −14.1% | SEC10b5-1 |
| 2026/9/321:05 ET | 2026/9/1 | Chapman Steven Leonard執行長、總裁 | S賣出Common Stock | −1,698 | $320.99 | −$54.5 萬 | 9.82 萬 | −1.7% | SEC10b5-1 |
| 2026/8/2821:35 ET | 2026/8/10 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | S賣出Common Stock | −6,517 | $321.53 | −$209.54 萬 | 19.73 萬 | −3.2% | SEC10b5-1 |
| 2026/8/1421:35 ET | 2026/8/10 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −6,000 | $325.3237 | −$195.19 萬 | 23.05 萬 | −2.5% | SEC10b5-1 |
| 2026/8/721:35 ET | 2026/8/7 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −2,000 | $320.90 | −$64.18 萬 | 2,000 | −50.0% | SEC10b5-1 |
| 2026/8/721:35 ET | 2026/8/7 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −9,150 | $315.664 | −$288.83 萬 | 23.65 萬 | −3.7% | SEC10b5-1 |
| 2026/8/521:35 ET | 2026/8/3–8/4 | Brophy Michael Burkes財務長 | S賣出Common Stock | −795 | $271.7356 | −$21.6 萬 | 5.16 萬 | −1.5% | SEC10b5-1 |
| 2026/8/521:35 ET | 2026/8/3 | Chapman Steven Leonard執行長、總裁 | S賣出Common Stock | −3,076 | $266.395 | −$81.94 萬 | 9.99 萬 | −3.0% | SEC10b5-1 |
| 2026/8/521:35 ET | 2026/8/3 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | S賣出Common Stock | −295 | $267.9893 | −$7.91 萬 | 18.38 萬 | −0.2% | SEC10b5-1 |
| 2026/8/521:35 ET | 2026/8/3 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | S賣出Common Stock | −3,410 | $265.5797 | −$90.56 萬 | 12.9 萬 | −2.6% | SEC10b5-1 |
| 2026/8/521:35 ET | 2026/8/3 | RABINOWITZ DANIEL公司秘書、法務長 | S賣出Common Stock | −334 | $267.9893 | −$8.95 萬 | 17.01 萬 | −0.2% | SEC10b5-1 |
| 2026/8/521:35 ET | 2026/8/3 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −731 | $267.9893 | −$19.59 萬 | 227.54 萬 | 0.0% | SEC10b5-1 |
| 2026/8/521:35 ET | 2026/8/3 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −109 | $267.9893 | −$2.92 萬 | 24.56 萬 | 0.0% | SEC10b5-1 |
| 2026/7/2921:35 ET | 2026/7/27–7/28 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −479 | $257.9304 | −$12.35 萬 | 24.57 萬 | −0.2% | SEC10b5-1 |
| 2026/7/2921:35 ET | 2026/7/27 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −1,718 | $260.4908 | −$44.75 萬 | 227.61 萬 | −0.1% | SEC10b5-1 |
| 2026/7/2921:35 ET | 2026/7/27–7/28 | RABINOWITZ DANIEL公司秘書、法務長 | S賣出Common Stock | −1,887 | $257.0782 | −$48.51 萬 | 17.04 萬 | −1.1% | SEC10b5-1 |
| 2026/7/2921:35 ET | 2026/7/27–7/28 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | S賣出Common Stock | −2,214 | $256.9994 | −$56.9 萬 | 13.24 萬 | −1.6% | SEC10b5-1 |
| 2026/7/2921:35 ET | 2026/7/27–7/28 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | S賣出Common Stock | −1,713 | $257.0014 | −$44.02 萬 | 18.41 萬 | −0.9% | SEC10b5-1 |
| 2026/7/2921:35 ET | 2026/7/27–7/28 | Chapman Steven Leonard執行長、總裁 | S賣出Common Stock | −5,770 | $256.5073 | −$148 萬 | 10.3 萬 | −5.3% | SEC10b5-1 |
| 2026/7/2921:35 ET | 2026/7/27–7/29 | Brophy Michael Burkes財務長 | S賣出Common Stock | −5,064 | $253.2848 | −$128.26 萬 | 5.24 萬 | −8.8% | SEC10b5-1 |
| 2026/7/1721:05 ET | 2026/7/15 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −1,500 | $273.8835 | −$41.08 萬 | 1.8 萬 | −7.7% | SEC10b5-1 |
| 2026/7/1721:05 ET | 2026/7/15 | Chapman Rowan E董事 | S賣出Common Stock | −135 | $274.82 | −$3.71 萬 | 4,663 | −2.8% | SEC10b5-1 |
| 2026/7/1521:05 ET | 2026/7/13 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −3,150 | $265.682 | −$83.69 萬 | 24.62 萬 | −1.3% | SEC10b5-1 |
| 2026/7/821:05 ET | 2026/7/6 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −1,000 | $280.00 | −$28 萬 | 4,000 | −20.0% | SEC10b5-1 |
| 2026/7/621:05 ET | 2026/7/1 | RABINOWITZ DANIEL公司秘書、法務長 | S賣出Common Stock | −1.68 萬 | $272.2875 | −$457.44 萬 | 17.23 萬 | −8.9% | SEC10b5-1 |
| 2026/7/621:05 ET | 2026/7/1 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | S賣出Common Stock | −3,000 | $272.9035 | −$81.87 萬 | 13.46 萬 | −2.2% | SEC10b5-1 |
| 2026/6/26 | 2026/6/24 | RABINOWITZ DANIEL公司秘書、法務長 | S賣出Common Stock | −3.36 萬 | $251.6489 | −$845.54 萬 | 18.91 萬 | −15.1% | SEC10b5-1 |
| 2026/6/26 | 2026/6/24 | ROSENMAN HERM董事 | S賣出Common Stock | −1.65 萬 | $250.00 | −$413.25 萬 | 4,250 | −79.5% | SEC10b5-1 |
| 2026/6/22 | 2026/6/17 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −1,500 | $219.875 | −$32.98 萬 | 1.88 萬 | −7.4% | SEC10b5-1 |
| 2026/6/17 | 2026/6/16 | Chapman Rowan E董事 | S賣出Common Stock | −2,964 | $216.78 | −$64.25 萬 | 3,124 | −48.7% | SEC10b5-1 |
| 2026/6/17 | 2026/6/15 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −3,150 | $211.1376 | −$66.51 萬 | 24.94 萬 | −1.2% | SEC10b5-1 |
| 2026/6/16 | 2026/6/12–6/15 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −10 萬 | $214.473 | −$2,144.73 萬 | 227.78 萬 | −4.2% | SEC10b5-1 |
| 2026/6/9 | 2026/6/5 | Marcus Gail Boxer董事 | S賣出Common Stock | −1.1 萬 | $217.2098 | −$238.93 萬 | 6,183 | −64.0% | SEC |
| 2026/6/5 | 2026/6/4 | Chapman Steven Leonard執行長、總裁 | S賣出Common Stock | −4.11 萬 | $221.0338 | −$908.98 萬 | 10.87 萬 | −27.4% | SEC10b5-1 |
| 2026/6/3 | 2026/6/1 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | S賣出Common Stock | −3,000 | $218.4315 | −$65.53 萬 | 13.76 萬 | −2.1% | SEC10b5-1 |
| 2026/6/3 | 2026/6/1 | BOTHA ROELOF董事 | S賣出Common Stock | −7.8 萬 | $220.3084 | −$1,718.41 萬 | 107.62 萬 | −6.8% | SEC |
| 2026/5/28 | 2026/5/26 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | S賣出Common Stock | −1,438 | $202.84 | −$29.17 萬 | 18.58 萬 | −0.8% | SEC10b5-1 |
| 2026/5/28 | 2026/5/26 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | S賣出Common Stock | −1,652 | $202.84 | −$33.51 萬 | 14.06 萬 | −1.2% | SEC10b5-1 |
| 2026/5/15 | 2026/5/8 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −3,150 | $208.6062 | −$65.71 萬 | 25.25 萬 | −1.2% | SEC10b5-1 |
| 2026/5/15 | 2026/5/13 | Sheena Jonathan董事、其他:CO-FOUNDER | S賣出Common Stock | −1,500 | $201.5618 | −$30.23 萬 | 1.95 萬 | −7.1% | SEC10b5-1 |
| 2026/5/6 | 2026/5/4–5/5 | Rabinowitz Matthew執行董事長 | S賣出Common Stock | −7,708 | $213.0528 | −$164.22 萬 | 237.78 萬 | −0.3% | SEC10b5-1 |
| 2026/5/5 | 2026/5/1 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | S賣出Common Stock | −291 | $206.16 | −$6 萬 | 18.72 萬 | −0.2% | SEC10b5-1 |
| 2026/5/5 | 2026/5/1 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | S賣出Common Stock | −3,405 | $203.6903 | −$69.36 萬 | 14.23 萬 | −2.3% | SEC10b5-1 |
| 2026/5/5 | 2026/5/1 | RABINOWITZ DANIEL公司秘書、法務長 | S賣出Common Stock | −330 | $206.16 | −$6.8 萬 | 22.27 萬 | −0.1% | SEC10b5-1 |
| 2026/5/5 | 2026/5/1 | Chapman Steven Leonard執行長、總裁 | S賣出Common Stock | −902 | $206.16 | −$18.6 萬 | 14.99 萬 | −0.6% | SEC10b5-1 |